Мы используем Cookies
Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Знаете ли вы?
Кликните два раза на слово, чтобы найти его в TermGallery.
Кликните два раза на слово, чтобы найти его в TermGallery.
Значения термина ps-341 на английском
Chemical compound.
Похожие термины
Синонимы
Examples for "bortezomib"
Examples for "bortezomib"
1
These biomarkers data begin to illuminate bortezomib's mechanism of action in lymphoma.
2
Results: Thirty-one per cent of patients received bortezomib beyond first relapse.
3
However, apoptotic response to bortezomib was not affected by the deletion of p53.
4
Recently, it has been shown that bortezomib treatment enhances OB function.
5
The safety profile was consistent with that reported for single-agent bortezomib and romidepsin.
1
The inhibitors tested included several peptide boronates, some of which proved to be the most potent peptide-based inhibitors of beta-amyloid production reported so far.
Использование термина ps-341 на английском
1
TUNEL staining indicated that PS-341 treatment sensitizes Tax tumors to DNA fragmentation.
2
In Tax transgenic mice, PS-341 administered thrice weekly inhibited tumor-associated NF-kappaB activity.
3
PSI suppressed the growth of AML cell lines more effectively than PS-341.
4
Both preclinical and clinical studies of novel agents including PS-341 and IMiDs are highlighted.
5
The tumor tissues treated with PS-341 show no consistent inhibition of NFkappaB activation in vivo.
6
Annexin V staining indicated that PS-341 response in vivo correlated with sensitivity to apoptosis induced by gamma irradiation.
7
However, the effect of PS-341 on the growth of tumors in Tax transgenic mice revealed heterogeneity in drug responsiveness.
8
Radiosensitization by PS-341 was reduced in fish with impaired p53 expression or function but not associated with enhanced expression of select p53 target genes.